CN1440772A - Composite Chinese medicine for treating bloat and its prepn process and quality control method - Google Patents
Composite Chinese medicine for treating bloat and its prepn process and quality control method Download PDFInfo
- Publication number
- CN1440772A CN1440772A CN 03109399 CN03109399A CN1440772A CN 1440772 A CN1440772 A CN 1440772A CN 03109399 CN03109399 CN 03109399 CN 03109399 A CN03109399 A CN 03109399A CN 1440772 A CN1440772 A CN 1440772A
- Authority
- CN
- China
- Prior art keywords
- pill
- weight portion
- ascites
- group
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 50
- 238000003908 quality control method Methods 0.000 title claims abstract description 10
- 239000002131 composite material Substances 0.000 title claims abstract description 8
- 230000008569 process Effects 0.000 title claims description 9
- 238000004886 process control Methods 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000000463 material Substances 0.000 claims abstract description 23
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 239000006187 pill Substances 0.000 claims description 117
- 238000011282 treatment Methods 0.000 claims description 50
- 238000012360 testing method Methods 0.000 claims description 43
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 36
- 238000000034 method Methods 0.000 claims description 33
- 239000000243 solution Substances 0.000 claims description 32
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 24
- 239000000706 filtrate Substances 0.000 claims description 21
- 239000008194 pharmaceutical composition Substances 0.000 claims description 18
- 229960004756 ethanol Drugs 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 15
- 210000000582 semen Anatomy 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 8
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 8
- 239000011230 binding agent Substances 0.000 claims description 8
- 239000012567 medical material Substances 0.000 claims description 8
- 238000010992 reflux Methods 0.000 claims description 8
- 239000000741 silica gel Substances 0.000 claims description 8
- 229910002027 silica gel Inorganic materials 0.000 claims description 8
- 239000011734 sodium Substances 0.000 claims description 8
- 238000004809 thin layer chromatography Methods 0.000 claims description 8
- 210000000003 hoof Anatomy 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 6
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 5
- 235000019640 taste Nutrition 0.000 claims description 5
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 claims description 4
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- DLUOMMXONAIKQD-UHFFFAOYSA-N OC=O.ClC(Cl)Cl.CCOC(C)=O Chemical compound OC=O.ClC(Cl)Cl.CCOC(C)=O DLUOMMXONAIKQD-UHFFFAOYSA-N 0.000 claims description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 4
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 claims description 4
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 claims description 4
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 4
- 238000003810 ethyl acetate extraction Methods 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 229910052742 iron Inorganic materials 0.000 claims description 4
- 238000007254 oxidation reaction Methods 0.000 claims description 4
- 239000003208 petroleum Substances 0.000 claims description 4
- 239000002244 precipitate Substances 0.000 claims description 4
- 238000001556 precipitation Methods 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 4
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 239000012085 test solution Substances 0.000 claims description 4
- 229940126680 traditional chinese medicines Drugs 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 238000012850 discrimination method Methods 0.000 claims description 3
- 238000006424 Flood reaction Methods 0.000 claims description 2
- 239000000890 drug combination Substances 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims 4
- 208000004880 Polyuria Diseases 0.000 abstract description 15
- 230000035619 diuresis Effects 0.000 abstract description 15
- 230000006870 function Effects 0.000 abstract description 7
- 210000000952 spleen Anatomy 0.000 abstract description 7
- 238000001035 drying Methods 0.000 abstract description 2
- 241000209140 Triticum Species 0.000 abstract 1
- 235000021307 Triticum Nutrition 0.000 abstract 1
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 abstract 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 abstract 1
- 238000007873 sieving Methods 0.000 abstract 1
- 230000008961 swelling Effects 0.000 abstract 1
- 206010003445 Ascites Diseases 0.000 description 139
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 62
- 210000002700 urine Anatomy 0.000 description 42
- 241001465754 Metazoa Species 0.000 description 40
- 208000009304 Acute Kidney Injury Diseases 0.000 description 38
- 241000700159 Rattus Species 0.000 description 27
- 240000002853 Nelumbo nucifera Species 0.000 description 24
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 24
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 24
- 208000024891 symptom Diseases 0.000 description 24
- 235000011187 glycerol Nutrition 0.000 description 21
- 230000000694 effects Effects 0.000 description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 18
- 230000000968 intestinal effect Effects 0.000 description 18
- 208000033626 Renal failure acute Diseases 0.000 description 17
- 201000011040 acute kidney failure Diseases 0.000 description 17
- 208000012998 acute renal failure Diseases 0.000 description 17
- 201000010099 disease Diseases 0.000 description 17
- 229940079593 drug Drugs 0.000 description 17
- 230000037396 body weight Effects 0.000 description 16
- 241000699666 Mus <mouse, genus> Species 0.000 description 14
- 230000002496 gastric effect Effects 0.000 description 14
- 238000001802 infusion Methods 0.000 description 14
- 201000009030 Carcinoma Diseases 0.000 description 12
- 102000009027 Albumins Human genes 0.000 description 11
- 108010088751 Albumins Proteins 0.000 description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 11
- 206010030113 Oedema Diseases 0.000 description 11
- 230000008859 change Effects 0.000 description 11
- 230000003187 abdominal effect Effects 0.000 description 10
- 238000000465 moulding Methods 0.000 description 10
- 208000019425 cirrhosis of liver Diseases 0.000 description 9
- 238000009826 distribution Methods 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 230000005484 gravity Effects 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 8
- 206010030302 Oliguria Diseases 0.000 description 7
- 210000001015 abdomen Anatomy 0.000 description 7
- 239000003651 drinking water Substances 0.000 description 7
- 235000020188 drinking water Nutrition 0.000 description 7
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 238000003748 differential diagnosis Methods 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 229960002003 hydrochlorothiazide Drugs 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 210000003462 vein Anatomy 0.000 description 5
- 238000012449 Kunming mouse Methods 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 230000003908 liver function Effects 0.000 description 4
- 210000003141 lower extremity Anatomy 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 230000002503 metabolic effect Effects 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 240000008620 Fagopyrum esculentum Species 0.000 description 3
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 229940082203 hydrochlorothiazide 15 mg Drugs 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 229960002362 neostigmine Drugs 0.000 description 3
- LULNWZDBKTWDGK-UHFFFAOYSA-M neostigmine bromide Chemical compound [Br-].CN(C)C(=O)OC1=CC=CC([N+](C)(C)C)=C1 LULNWZDBKTWDGK-UHFFFAOYSA-M 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- LXMSZDCAJNLERA-ZHYRCANASA-N spironolactone Chemical compound C([C@@H]1[C@]2(C)CC[C@@H]3[C@@]4(C)CCC(=O)C=C4C[C@H]([C@@H]13)SC(=O)C)C[C@@]21CCC(=O)O1 LXMSZDCAJNLERA-ZHYRCANASA-N 0.000 description 3
- 229960002256 spironolactone Drugs 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010041660 Splenomegaly Diseases 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 230000007159 enucleation Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 2
- 210000004279 orbit Anatomy 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 208000007232 portal hypertension Diseases 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 235000002639 sodium chloride Nutrition 0.000 description 2
- -1 suspensoid Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010009208 Cirrhosis alcoholic Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000003623 Hypoalbuminemia Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 206010053583 Peritoneal tuberculosis Diseases 0.000 description 1
- 208000002151 Pleural effusion Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010061481 Renal injury Diseases 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000008744 Tuberculous Peritonitis Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 208000010002 alcoholic liver cirrhosis Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000002274 chylous ascites Diseases 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- FSEUPUDHEBLWJY-HWKANZROSA-N diacetylmonoxime Chemical compound CC(=O)C(\C)=N\O FSEUPUDHEBLWJY-HWKANZROSA-N 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000011863 diuretic therapy Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 201000001505 hemoglobinuria Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000036732 histological change Effects 0.000 description 1
- 229940082223 hydrochlorothiazide 30 mg Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 238000009592 kidney function test Methods 0.000 description 1
- 208000037806 kidney injury Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- OSZNNLWOYWAHSS-UHFFFAOYSA-M neostigmine methyl sulfate Chemical compound COS([O-])(=O)=O.CN(C)C(=O)OC1=CC=CC([N+](C)(C)C)=C1 OSZNNLWOYWAHSS-UHFFFAOYSA-M 0.000 description 1
- 229960002253 neostigmine methylsulfate Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 210000003240 portal vein Anatomy 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001141 propulsive effect Effects 0.000 description 1
- 238000001814 protein method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000004260 weight control Methods 0.000 description 1
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03109399 CN1283304C (en) | 2003-04-08 | 2003-04-08 | Composite Chinese medicine for treating bloat and its prepn process and quality control method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03109399 CN1283304C (en) | 2003-04-08 | 2003-04-08 | Composite Chinese medicine for treating bloat and its prepn process and quality control method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1440772A true CN1440772A (en) | 2003-09-10 |
CN1283304C CN1283304C (en) | 2006-11-08 |
Family
ID=27770216
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 03109399 Expired - Lifetime CN1283304C (en) | 2003-04-08 | 2003-04-08 | Composite Chinese medicine for treating bloat and its prepn process and quality control method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1283304C (en) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1319709C (en) * | 2003-10-20 | 2007-06-06 | 三金集团桂林三金生物药业有限责任公司 | Swordleaf dragon tree resiniferous wood quality control method |
CN101229248A (en) * | 2008-01-21 | 2008-07-30 | 邯郸制药有限公司 | Quality standard and test method of hoove pill and preparation threrewith |
CN101406654B (en) * | 2007-10-12 | 2011-04-13 | 王学岭 | Oral liquid for treating hoove |
CN102305840A (en) * | 2008-01-21 | 2012-01-04 | 邯郸摩罗丹药业股份有限公司 | Hoove pill and quality standard and test method for preparation of hoove pill |
CN104771556A (en) * | 2015-03-17 | 2015-07-15 | 黄萍 | Traditional Chinese medicine composition for treating tympanites caused by qi stagnation and damp obstruction |
CN105749015A (en) * | 2016-04-28 | 2016-07-13 | 邯郸制药股份有限公司 | Traditional Chinese medicine for treating hoove and preparation of traditional Chinese medicine composition |
CN105749016A (en) * | 2016-04-28 | 2016-07-13 | 邯郸制药股份有限公司 | Traditional Chinese medicine composition for treating hoove and preparation of traditional Chinese medicine composition |
CN105749020A (en) * | 2016-04-28 | 2016-07-13 | 邯郸制药股份有限公司 | Traditional Chinese medicine composition for treating hoove and preparation of traditional Chinese medicine composition |
CN105749017A (en) * | 2016-04-28 | 2016-07-13 | 邯郸制药股份有限公司 | Traditional Chinese medicine composition for treating hoove and preparation of traditional Chinese medicine composition |
CN105749018A (en) * | 2016-04-28 | 2016-07-13 | 邯郸制药股份有限公司 | Traditional Chinese medicine composition for treating hoove and preparation of traditional Chinese medicine composition |
CN105749019A (en) * | 2016-04-28 | 2016-07-13 | 邯郸制药股份有限公司 | Traditional Chinese medicine composition for treating hoove and preparation of traditional Chinese medicine composition |
CN105770567A (en) * | 2016-04-28 | 2016-07-20 | 邯郸制药股份有限公司 | Traditional Chinese medicine composition for treating hoove and preparation thereof |
CN105770566A (en) * | 2016-04-28 | 2016-07-20 | 邯郸制药股份有限公司 | Traditional Chinese medicine composition for treating hoove and preparation thereof |
CN105796976A (en) * | 2016-04-28 | 2016-07-27 | 邯郸制药股份有限公司 | Traditional Chinese medicine composition and preparation capable of treating hoove |
CN105796975A (en) * | 2016-04-28 | 2016-07-27 | 邯郸制药股份有限公司 | Traditional Chinese medicine composition capable of treating hoove |
CN105920389A (en) * | 2016-04-28 | 2016-09-07 | 邯郸制药股份有限公司 | Traditional Chinese medicinal composition for treating hoove and preparation of traditional Chinese medicinal composition |
CN105920390A (en) * | 2016-04-28 | 2016-09-07 | 邯郸制药股份有限公司 | Traditional Chinese medicinal composition for treating hoove and preparation of traditional Chinese medicinal composition |
-
2003
- 2003-04-08 CN CN 03109399 patent/CN1283304C/en not_active Expired - Lifetime
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1319709C (en) * | 2003-10-20 | 2007-06-06 | 三金集团桂林三金生物药业有限责任公司 | Swordleaf dragon tree resiniferous wood quality control method |
CN101406654B (en) * | 2007-10-12 | 2011-04-13 | 王学岭 | Oral liquid for treating hoove |
CN101229248A (en) * | 2008-01-21 | 2008-07-30 | 邯郸制药有限公司 | Quality standard and test method of hoove pill and preparation threrewith |
CN102305840A (en) * | 2008-01-21 | 2012-01-04 | 邯郸摩罗丹药业股份有限公司 | Hoove pill and quality standard and test method for preparation of hoove pill |
CN101229248B (en) * | 2008-01-21 | 2013-10-30 | 邯郸摩罗丹药业股份有限公司 | Quality standard and test method of hoove pill and detection method |
CN102305840B (en) * | 2008-01-21 | 2014-01-22 | 邯郸摩罗丹药业股份有限公司 | Hoove pill and quality standard and test method for preparation of hoove pill |
CN104771556A (en) * | 2015-03-17 | 2015-07-15 | 黄萍 | Traditional Chinese medicine composition for treating tympanites caused by qi stagnation and damp obstruction |
CN105749016A (en) * | 2016-04-28 | 2016-07-13 | 邯郸制药股份有限公司 | Traditional Chinese medicine composition for treating hoove and preparation of traditional Chinese medicine composition |
CN105749015A (en) * | 2016-04-28 | 2016-07-13 | 邯郸制药股份有限公司 | Traditional Chinese medicine for treating hoove and preparation of traditional Chinese medicine composition |
CN105749020A (en) * | 2016-04-28 | 2016-07-13 | 邯郸制药股份有限公司 | Traditional Chinese medicine composition for treating hoove and preparation of traditional Chinese medicine composition |
CN105749017A (en) * | 2016-04-28 | 2016-07-13 | 邯郸制药股份有限公司 | Traditional Chinese medicine composition for treating hoove and preparation of traditional Chinese medicine composition |
CN105749018A (en) * | 2016-04-28 | 2016-07-13 | 邯郸制药股份有限公司 | Traditional Chinese medicine composition for treating hoove and preparation of traditional Chinese medicine composition |
CN105749019A (en) * | 2016-04-28 | 2016-07-13 | 邯郸制药股份有限公司 | Traditional Chinese medicine composition for treating hoove and preparation of traditional Chinese medicine composition |
CN105770567A (en) * | 2016-04-28 | 2016-07-20 | 邯郸制药股份有限公司 | Traditional Chinese medicine composition for treating hoove and preparation thereof |
CN105770566A (en) * | 2016-04-28 | 2016-07-20 | 邯郸制药股份有限公司 | Traditional Chinese medicine composition for treating hoove and preparation thereof |
CN105796976A (en) * | 2016-04-28 | 2016-07-27 | 邯郸制药股份有限公司 | Traditional Chinese medicine composition and preparation capable of treating hoove |
CN105796975A (en) * | 2016-04-28 | 2016-07-27 | 邯郸制药股份有限公司 | Traditional Chinese medicine composition capable of treating hoove |
CN105920389A (en) * | 2016-04-28 | 2016-09-07 | 邯郸制药股份有限公司 | Traditional Chinese medicinal composition for treating hoove and preparation of traditional Chinese medicinal composition |
CN105920390A (en) * | 2016-04-28 | 2016-09-07 | 邯郸制药股份有限公司 | Traditional Chinese medicinal composition for treating hoove and preparation of traditional Chinese medicinal composition |
Also Published As
Publication number | Publication date |
---|---|
CN1283304C (en) | 2006-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1283304C (en) | Composite Chinese medicine for treating bloat and its prepn process and quality control method | |
CN100337662C (en) | Medicinal composition for treating hyperlipemia and its preparing method | |
CN1457829A (en) | Chinese medicine composition for curing chronic atrophic sastritis and its preparing method and quality control method | |
CN1233387C (en) | Chinese compound medicine for treating anhypnosis and its preparation metod | |
CN1228074C (en) | Chinese traditional medicine for treating immune hypofunction and disfunction | |
CN102240318A (en) | Traditional Chinese medicine for tonifying qi and increasing breast milk | |
CN1446577A (en) | Medicine combination for treating child fastidium | |
CN1709376A (en) | Compound Chinese medicine formulation for treating qi stagnation epigastralgia, and its preparing method | |
CN1698878A (en) | Kidney replenishing medicinal composition and its preparation process and novel use | |
CN1813819A (en) | Hedgehog hydnum fruiting body or hyphostroma and culture extract and formulation and preparing method | |
CN1692933A (en) | Compound traditional Chinese medicine for treating proliferation of mammary gland, and its prepn. method | |
CN1248718C (en) | Medicinal composition for treating mycoplasma pneumonia and preparation method and quality-control method | |
CN1857670A (en) | Medicine for treating hyperplasia of mammary glands and its preparing method | |
CN1548138A (en) | Chinese medicine composition for treating consumptive disease and its quality control method | |
CN1194735C (en) | Chinese medicine for treating hyperplasia of mammary glands | |
CN1899536A (en) | Medicine for treating diabetes and hephrosis and its preparing method | |
CN1297290C (en) | Medicinal composition for treating coronary heart disease and stenocardia and its preparation method | |
CN1301129C (en) | Medication for treating arthralgia due to wind-cold dampness and weary muscles and bones | |
CN1733089A (en) | Medicine for treating diabetes and its complications and process for preparing the same | |
CN112755160A (en) | Traditional Chinese medicine composition for improving postoperative prognosis of breast cancer and application thereof | |
CN101062314A (en) | Medicine for curing gout and its preparing method | |
CN1112197C (en) | Chinese medicine preparation for treating precancerous lesion of atrophic gastritis | |
CN1679693A (en) | Medicine for treating hepatopathy and preparation thereof | |
CN1990022A (en) | Traditional Chinese medicine composition, its preparation and quality controlling means | |
CN104257960A (en) | Traditional Chinese medicine composition for treating non-alcoholic fatty liver disease and applications of composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CI01 | Publication of corrected invention patent application |
Correction item: Denomination of Invention Correct: The quality control method of a traditional Chinese medicine composition for treating Hoove. False: Quality control method of traditional Chinese medicine composition for treating swelling disease Number: 45 Page: 926 Volume: 22 |
|
CI03 | Correction of invention patent |
Correction item: Denomination of Invention Correct: The quality control method of a traditional Chinese medicine composition for treating Hoove. False: Quality control method of traditional Chinese medicine composition for treating swelling disease Number: 45 Page: The title page Volume: 22 |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTION NAME; FROM: QUALITY CONTROLLING MEANS OF A CHINESE MEDICINAL COMPOSITION FOR THE TREATMENT OF SWELLING DISEASE TO: A QUALITY CONTROL METHOD OF A CHINESE MEDICINAL COMPOSITION CURING TYMPANITES |
|
ERR | Gazette correction |
Free format text: CORRECT: INVENTION NAME; FROM: QUALITY CONTROLLING MEANS OF A CHINESE MEDICINAL COMPOSITION FOR THE TREATMENT OF SWELLING DISEASE TO: A QUALITY CONTROL METHOD OF A CHINESE MEDICINAL COMPOSITION CURING TYMPANITES |
|
C56 | Change in the name or address of the patentee |
Owner name: HANDAN MOLUODAN PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: HANDAN PHARMACEUTICAL CO., LTD. |
|
CP03 | Change of name, title or address |
Address after: 056005 No. 309 National Road, Handan Hebei Industrial Park, No. 18 Patentee after: HANDAN MOLUODAN PHARMACEUTICAL Co.,Ltd. Address before: 056001 No. 321 Heping Road, Hebei, Handan Patentee before: HANDAN PHARMACEUTICAL Co.,Ltd. |
|
C56 | Change in the name or address of the patentee |
Owner name: HANDAN PHARMACY CO., LTD. Free format text: FORMER NAME: HANDAN MOLUODAN PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 056005 No. 309 National Road, Handan Hebei Industrial Park, No. 18 Patentee after: HANDAN PHARMACEUTICAL Co.,Ltd. Address before: 056005 No. 309 National Road, Handan Hebei Industrial Park, No. 18 Patentee before: HANDAN MOLUODAN PHARMACEUTICAL Co.,Ltd. |
|
CX01 | Expiry of patent term |
Granted publication date: 20061108 |
|
CX01 | Expiry of patent term |